These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 29043964)
1. Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009. Peckeu L; Delasnerie-Lauprètre N; Brandel JP; Salomon D; Sazdovitch V; Laplanche JL; Duyckaerts C; Seilhean D; Haïk S; Hauw JJ Euro Surveill; 2017 Oct; 22(41):. PubMed ID: 29043964 [TBL] [Abstract][Full Text] [Related]
2. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010 [TBL] [Abstract][Full Text] [Related]
3. Comparison Between Sporadic and Misdiagnosed Sporadic Creutzfeldt-Jakob Disease: A Report of Two Cases. Zhao X; Yu Y; Zhao Z; Xu J Cell Biochem Biophys; 2015 Jun; 72(2):311-5. PubMed ID: 25556070 [TBL] [Abstract][Full Text] [Related]
4. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Collins SJ; Sanchez-Juan P; Masters CL; Klug GM; van Duijn C; Poleggi A; Pocchiari M; Almonti S; Cuadrado-Corrales N; de Pedro-Cuesta J; Budka H; Gelpi E; Glatzel M; Tolnay M; Hewer E; Zerr I; Heinemann U; Kretszchmar HA; Jansen GH; Olsen E; Mitrova E; Alpérovitch A; Brandel JP; Mackenzie J; Murray K; Will RG Brain; 2006 Sep; 129(Pt 9):2278-87. PubMed ID: 16816392 [TBL] [Abstract][Full Text] [Related]
5. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Castellani RJ; Colucci M; Xie Z; Zou W; Li C; Parchi P; Capellari S; Pastore M; Rahbar MH; Chen SG; Gambetti P Neurology; 2004 Aug; 63(3):436-42. PubMed ID: 15304573 [TBL] [Abstract][Full Text] [Related]
7. Additional value of tau protein measurement in the diagnosis of Creutzfeldt-Jakob disease. Cseh EK; Veres G; Danics K; Szalárdy L; Nánási N; Klivényi P; Vécsei L; Zádori D Ideggyogy Sz; 2019 Jan; 72(1-2):39-47. PubMed ID: 30785245 [TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008. Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221 [TBL] [Abstract][Full Text] [Related]
9. Real-time quaking-induced conversion assay using a small-scale substrate production workflow for the diagnosis of Creutzfeldt-Jakob disease. Thanapornsangsuth P; Chongsuksantikul A; Saraya AW; Hiransuthikul A; Hemachudha T J Neurochem; 2023 Jul; 166(2):403-413. PubMed ID: 37163217 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review. Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282 [TBL] [Abstract][Full Text] [Related]
11. High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD. Fiorini M; Iselle G; Perra D; Bongianni M; Capaldi S; Sacchetto L; Ferrari S; Mombello A; Vascellari S; Testi S; Monaco S; Zanusso G Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019068 [TBL] [Abstract][Full Text] [Related]
12. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy. Mastrangelo A; Mammana A; Baiardi S; Tiple D; Colaizzo E; Rossi M; Vaianella L; Polischi B; Equestre M; Poleggi A; Capellari S; Ladogana A; Parchi P J Neurol Neurosurg Psychiatry; 2023 Feb; 94(2):121-129. PubMed ID: 36428087 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3. Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC. Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342 [TBL] [Abstract][Full Text] [Related]
17. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Zerr I; Kallenberg K; Summers DM; Romero C; Taratuto A; Heinemann U; Breithaupt M; Varges D; Meissner B; Ladogana A; Schuur M; Haik S; Collins SJ; Jansen GH; Stokin GB; Pimentel J; Hewer E; Collie D; Smith P; Roberts H; Brandel JP; van Duijn C; Pocchiari M; Begue C; Cras P; Will RG; Sanchez-Juan P Brain; 2009 Oct; 132(Pt 10):2659-68. PubMed ID: 19773352 [TBL] [Abstract][Full Text] [Related]